We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Glenmark Pharmaceuticals Europe (Glenmark) has secured final approval from the UK Medicines and Healthcare products Regulatory Agency (MHRA) for Maloff Protect, its range of atovaquone / proguanil film-coated tablets.